A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism

被引:49
作者
Egelund, R
Petersen, TE
Andreasen, PA
机构
[1] Aarhus Univ, Dept Biol Mol & Struct, Lab Cellular Prot Sci, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ, Dept Biol Mol & Struct, Prot Chem Lab, DK-8000 Aarhus, Denmark
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2001年 / 268卷 / 03期
关键词
plasminogen activator inhibitor type-1 (PAI-1); serine proteinase; serpin; urokinase-type plasminogen activator (uPA);
D O I
10.1046/j.1432-1327.2001.01921.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The formation of stable complexes between serpins and their target serine proteinases indicates formation of an ester bond between the proteinase active-site serine and the serpin P-1 residue [Egelund, R., Rodenburg, K.W., Andreasen, P.A., Rasmussen, M.S., Guldberg, R.E. & Petersen, T.E. (1998) Biochemistry 37, 6375-6379]. An important question concerning serpin inhibition is the contrast between the stability of the ester bond in the complex and the rapid hydrolysis of the acyl-enzyme intermediate in general serine proteinase-catalysed peptide bond hydrolysis. To answer this question, we used limited proteolysis to detect conformational differences between free urokinase-type plasminogen activator (uPA) and uPA in complex with plasminogen activator inhibitor-1 (PAI-1). Whereas the catalytic domain of free uPA, pro-uPA, uPA in complex with non-serpin inhibitors and anhydro-uPA in a non-covalent complex with PAI-1 was resistant to proteolysis, the catalytic domain of PAI-l-complexed uPA was susceptible to proteolysis. The cleavage sites for four different proteinases were localized in specific areas of the C-terminal P-barrel of the catalytic domain of uPA, providing evidence that the serpin inhibitory mechanism involves a serpin-induced massive rearrangement of the proteinase active site, including the specificity pocket, the oxyanion hole, and main-chain binding area, rendering the proteinase unable to complete the normal hydrolysis of the acyl-enzyme intermediate. The distorted region includes the so-called activation domain, also known to change conformation on zymogen activation.
引用
收藏
页码:673 / 685
页数:13
相关论文
共 52 条
[1]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[2]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[3]  
2-Z
[4]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[5]  
[Anonymous], FOLD DES
[6]   Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function [J].
Bode, W ;
Renatus, M .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1997, 7 (06) :865-872
[7]   ANALYSIS OF PROTEIN AND PEPTIDE MIXTURES - EVALUATION OF 3 SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL-ELECTROPHORESIS BUFFER SYSTEMS [J].
BURY, AF .
JOURNAL OF CHROMATOGRAPHY, 1981, 213 (03) :491-500
[8]  
Carrell RW, 1996, BIOL CHEM H-S, V377, P1
[9]  
Christensen L, 1996, INT J CANCER, V66, P441
[10]   Type-1 plasminogen-activator inhibitor - Conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility [J].
Egelund, R ;
Schousboe, SL ;
SottrupJensen, L ;
Rodenburg, KW ;
Andreasen, PA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (03) :775-785